Mandate

Vinge advises M42 on its acquisition of Diaverum from Bridgepoint

May 22, 2023 M&A

Vinge is advising M42, an Abu Dhabi-based tech-enabled healthcare company in connection with is acquisition of Diaverum AB.

M42 is a global tech-enabled healthcare leader operating at the forefront of medical development. Diaverum is currently the world’s third-largest provider of dialysis services, operating across 23 countries, with 440 clinics and over 13,000 employees. The acquisition of Diaverum significantly expands M42’s global geographic footprint, enabling it to introduce relevant healthcare services and healthtech solutions in new markets while further enhancing its renal care offering in the GCC. The transaction, which is subject to customary regulatory approvals, is expected to close later in 2023.

Vinges team consisted of Matthias Pannier, Stina Bengtsson, Christoffer Nordin, Josefin Lanker och Josef Groow.

 

Related

Vinge advises Hallbyggarna Jonsereds in conjunction with the acquisition of Renthall

Hallbyggarna Jonsereds AB, part of the NSS Group, has acquired Renthall i Sverige AB, which has a turnover of SEK 40 million.
October 02, 2025

Vinge has advised in connection with the sale of Täby Air Maintenance AB and three Saab 2000 aircraft

Vinge has advised Erik Thun AB in connection with the sale of all shares in Täby Air Maintenance AB and three Saab 2000 aircraft to Wingefors Depå Sju AB.
October 02, 2025

Vinge advises Tengbom in connection with the acquisition of Suunnittelemo

Tengbom Finland is expanding and has established operations in Finland through the acquisition of Suunnittelemo Oy in Tammerfors.
October 01, 2025